Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 39 citing Gilbert: Meta-analysis of the effect of diabetes on restenosis rates among patients receiving.... (0.10 sec) 

Gender-specific care of the patient with diabetes: review and recommendations


MJ Legato, A Gelzer, R Goland, SA Ebner, S Rajan, V … - Gender Medicine, 2006 - Elsevier
Even when women were included in clinical trials, investigators typically made no attempt to
assess the impact of sex differences on the reported results. Existing studies, however, reveal
several differences between men and women with diabetes. The prevalence of DM is ...
Cited by 62 - Related articles - All 3 versions

Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect …

- nih.gov
C Stettler, S Allemann, M Egger, S Windecker, B … - British Medical …, 2006 - heart.bmj.com
Results: The analysis was based on 10 trials (six with sirolimus, four with paclitaxel), 4513 patients
(1146 patients with diabetes), 5755 years of follow up, and 2464 events. In patients without diabetes
sirolimus eluting stents were superior to paclitaxel eluting stents with respect to in-stent ( ...
Cited by 55 - Related articles - All 9 versions

[CITATION] Drug-eluting stents: meta-analysis in diabetic patients

- oxfordjournals.org [PDF] 
AJ Scheen, F Warzee, VMG Legrand - European heart journal, 2004 - Eur Soc Cardiology
We read with interest the systematic re- view on drug-eluting stents (DES) by Hill et al. 1 The
early data available indicate that DES reduce in-stent restenosis and major adverse cardiac
events (MACE), mainly revascularizations. Although diabe- tes mellitus represents a ...
Cited by 41 - Related articles - All 3 versions

Two-year clinical outcomes with drug-eluting stents for diabetic patients with de …

- ahajournals.org
P Ortolani, M Balducelli, P Marzaroli, G Piovaccari, A … - Circulation, 2008 - Am Heart Assoc
From the Istituto di Cardiologia, Università di Bologna, Policlinico S. Orsola-Malpighi (PO,
FS, RMTC, A. Marzocchi); Unità Operativa di Cardiologia–Centro Interventistico, Ospedale
S. Maria delle Croci, Ravenna (MB, A. Maresta); Unità Operativa di Cardiologia, ...
Cited by 31 - Related articles - All 8 versions

Metabolic syndrome and risk of restenosis in patients undergoing percutaneous …

- diabetesjournals.org
JS Rana, PS Monraats, AH Zwinderman, MPM de … - Diabetes Care, 2005 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—To assess the role of metabolic syndrome in the development
of restenosis, we performed an analysis in a population of patients from the GENetic DEterminants
of Restenosis (GENDER) study. The GENDER project, a multicenter prospective study, ...
Cited by 29 - Related articles - All 7 versions

Restenosis following implantation of bare metal coronary stents: pathophysiology …


NA Scott - Advanced drug delivery reviews, 2006 - Elsevier
This review summarizes the restenotic process that occurs after the implantation of bare metal
coronary stents. The pathology of in-stent restenosis is distinct from that seen after balloon angioplasty
and is characterized by neointimal proliferation and extracellular matrix deposition. The ...
Cited by 26 - Related articles - All 5 versions

Thiazolidinediones and risk of repeat target vessel revascularization following …


DM Riche, R Valderrama, NN Henyan - Diabetes Care, 2007 - Am Diabetes Assoc
OBJECTIVE—Thiazolidinediones (TZDs) (rosiglitazone and pioglitazone) are a class of antidiabetes
agents that have a high affinity for peroxisome proliferator–activated receptor-γ. TZDs initiate
a multitude of physiologic processes that may elicit benefits as systemic agents for the ...
Cited by 26 - Related articles - All 6 versions

Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary …

- diabetesjournals.org [PDF] 
AJ Scheen, F Warzée - Diabetes Care, 2004 - Am Diabetes Assoc
We describe a previously unre- ported clinical scenario of remit- ting diabetes in two young brothers
who do not fit existing diagnos- tic classifications. They may represent a new genetic subgroup
of diabetes. Case 1 presented at 3.6 years with poor linear growth, polyuria, and poly- ...
Cited by 20 - Related articles - BL Direct - All 5 versions

Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery …


PP Dobesh, ZA Stacy, AJ Ansara, JM Enders - Pharmacotherapy, 2004 - PPI
Coronary artery disease is the largest killer of men and women in the United States and costs
the health care system billions of dollars annually. Several advances in both mechanical and
pharmacologic treatment of coronary artery disease have occurred in recent decades. ...
Cited by 18 - Related articles - BL Direct - All 5 versions

Percutaneous coronary interventions with drug eluting stents for diabetic patients


R Seabra‐Gomes - Heart, 2006 - pubmedcentral.nih.gov
Type 2 diabetes is by far the most common form of diabetes mellitus, and is estimated to reach
epidemic proportions within the next 20 years. Diabetes is now considered an inflammatory,
atherothrombotic, insulin resistance syndrome. Genetic predisposition may be important ...
Cited by 10 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google